CHD4




For the TC LID, see Thamesford (Harydale Farms) Aerodrome.





























































CHD4







Available structures
PDB Ortholog search: PDBe RCSB



Identifiers
Aliases
CHD4, CHD-4, Mi-2b, Mi2-BETA, chromodomain helicase DNA binding protein 4, SIHIWES
External IDs MGI: 1344380 HomoloGene: 68175 GeneCards: CHD4


















Gene location (Human)
Chromosome 12 (human)
Chr. Chromosome 12 (human)[1]

Chromosome 12 (human)
Genomic location for CHD4

Genomic location for CHD4

Band 12p13.31 Start 6,570,082 bp[1]
End 6,614,524 bp[1]























RNA expression pattern

PBB GE CHD4 201182 s at fs.png

PBB GE CHD4 201183 s at fs.png

PBB GE CHD4 201184 s at fs.png
More reference expression data















Orthologs
Species Human Mouse
Entrez


1108


107932
Ensembl


ENSG00000111642


ENSMUSG00000063870
UniProt


Q14839


Q6PDQ2
RefSeq (mRNA)


NM_001273
NM_001297553
NM_001363606


NM_145979
NM_001346610
RefSeq (protein)


NP_001264
NP_001284482
NP_001350535


NP_001333539
NP_666091
Location (UCSC) Chr 12: 6.57 – 6.61 Mb Chr 6: 125.1 – 125.13 Mb

PubMed search		 [3] [4]
Wikidata



View/Edit Human View/Edit Mouse

Chromodomain-helicase-DNA-binding protein 4 is an enzyme that in humans is encoded by the CHD4 gene.[5][6][7]




Contents






  • 1 Function


  • 2 Interactions


  • 3 References


  • 4 External links


  • 5 Further reading





Function


The product of this gene belongs to the SNF2/RAD54 helicase family. It represents the main component of the nucleosome remodeling and deacetylase complex and plays an important role in epigenetic transcriptional repression. Patients with dermatomyositis develop antibodies against this protein.[7]



Interactions


CHD4 has been shown to interact with HDAC1,[8][9][10]Histone deacetylase 2,[10][11][12]MTA2,[8]SATB1[13] and Ataxia telangiectasia and Rad3 related.[12]



References





  1. ^ abc GRCh38: Ensembl release 89: ENSG00000111642 - Ensembl, May 2017


  2. ^ abc GRCm38: Ensembl release 89: ENSMUSG00000063870 - Ensembl, May 2017


  3. ^ "Human PubMed Reference:"..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  4. ^ "Mouse PubMed Reference:".


  5. ^ Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E (Oct 1995). "The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation". Arthritis and Rheumatism. 38 (10): 1389–99. doi:10.1002/art.1780381006. PMID 7575689.


  6. ^ Seelig HP, Renz M, Targoff IN, Ge Q, Frank MB (Oct 1996). "Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen". Arthritis and Rheumatism. 39 (10): 1769–71. doi:10.1002/art.1780391029. PMID 8843877.


  7. ^ ab "Entrez Gene: CHD4 chromodomain helicase DNA binding protein 4".


  8. ^ ab Yao YL, Yang WM (Oct 2003). "The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity". The Journal of Biological Chemistry. 278 (43): 42560–8. doi:10.1074/jbc.M302955200. PMID 12920132.


  9. ^ Grozinger CM, Hassig CA, Schreiber SL (Apr 1999). "Three proteins define a class of human histone deacetylases related to yeast Hda1p". Proceedings of the National Academy of Sciences of the United States of America. 96 (9): 4868–73. doi:10.1073/pnas.96.9.4868. PMC 21783. PMID 10220385.


  10. ^ ab Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL (Oct 1998). "Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex". Nature. 395 (6705): 917–21. doi:10.1038/27699. PMID 9804427.


  11. ^ Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R (Feb 2003). "A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes". The Journal of Biological Chemistry. 278 (9): 7234–9. doi:10.1074/jbc.M208992200. PMID 12493763.


  12. ^ ab Schmidt DR, Schreiber SL (Nov 1999). "Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4". Biochemistry. 38 (44): 14711–7. CiteSeerX 10.1.1.559.7745. doi:10.1021/bi991614n. PMID 10545197.


  13. ^ Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (Oct 2002). "SATB1 targets chromatin remodelling to regulate genes over long distances". Nature. 419 (6907): 641–5. doi:10.1038/nature01084. PMID 12374985.




External links


  • Human CHD4 genome location and CHD4 gene details page in the UCSC Genome Browser.


Further reading


.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}



  • Denslow SA, Wade PA (Aug 2007). "The human Mi-2/NuRD complex and gene regulation". Oncogene. 26 (37): 5433–8. doi:10.1038/sj.onc.1210611. PMID 17694084.


  • Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN (Oct 1995). "Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen". The Journal of Clinical Investigation. 96 (4): 1730–7. doi:10.1172/JCI118218. PMC 185809. PMID 7560064.


  • Woodage T, Basrai MA, Baxevanis AD, Hieter P, Collins FS (Oct 1997). "Characterization of the CHD family of proteins". Proceedings of the National Academy of Sciences of the United States of America. 94 (21): 11472–7. doi:10.1073/pnas.94.21.11472. PMC 23509. PMID 9326634.


  • Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D (Oct 1998). "The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities". Cell. 95 (2): 279–89. doi:10.1016/S0092-8674(00)81758-4. PMID 9790534.


  • Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL (Oct 1998). "Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex". Nature. 395 (6705): 917–21. doi:10.1038/27699. PMID 9804427.


  • Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D (Aug 1999). "Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation". Genes & Development. 13 (15): 1924–35. doi:10.1101/gad.13.15.1924. PMC 316920. PMID 10444591.


  • Schmidt DR, Schreiber SL (Nov 1999). "Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4". Biochemistry. 38 (44): 14711–7. CiteSeerX 10.1.1.559.7745. doi:10.1021/bi991614n. PMID 10545197.


  • Humphrey GW, Wang Y, Russanova VR, Hirai T, Qin J, Nakatani Y, Howard BH (Mar 2001). "Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1". The Journal of Biological Chemistry. 276 (9): 6817–24. doi:10.1074/jbc.M007372200. PMID 11102443.


  • Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, Steen H, Mann M, Lamond AI (Jan 2002). "Directed proteomic analysis of the human nucleolus". Current Biology. 12 (1): 1–11. doi:10.1016/S0960-9822(01)00650-9. PMID 11790298.


  • Koipally J, Georgopoulos K (Aug 2002). "A molecular dissection of the repression circuitry of Ikaros". The Journal of Biological Chemistry. 277 (31): 27697–705. doi:10.1074/jbc.M201694200. PMID 12015313.


  • Saito M, Ishikawa F (Sep 2002). "The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2". The Journal of Biological Chemistry. 277 (38): 35434–9. doi:10.1074/jbc.M203455200. PMID 12124384.


  • Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R (Feb 2003). "A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes". The Journal of Biological Chemistry. 278 (9): 7234–9. doi:10.1074/jbc.M208992200. PMID 12493763.


  • Kwan AH, Gell DA, Verger A, Crossley M, Matthews JM, Mackay JP (Jul 2003). "Engineering a protein scaffold from a PHD finger". Structure. 11 (7): 803–13. doi:10.1016/S0969-2126(03)00122-9. PMID 12842043.


  • Shimono Y, Murakami H, Kawai K, Wade PA, Shimokata K, Takahashi M (Dec 2003). "Mi-2 beta associates with BRG1 and RET finger protein at the distinct regions with transcriptional activating and repressing abilities". The Journal of Biological Chemistry. 278 (51): 51638–45. doi:10.1074/jbc.M309198200. PMID 14530259.


  • Williams CJ, Naito T, Arco PG, Seavitt JR, Cashman SM, De Souza B, Qi X, Keables P, Von Andrian UH, Georgopoulos K (Jun 2004). "The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development". Immunity. 20 (6): 719–33. doi:10.1016/j.immuni.2004.05.005. PMID 15189737.


  • Lehner B, Sanderson CM (Jul 2004). "A protein interaction framework for human mRNA degradation". Genome Research. 14 (7): 1315–23. doi:10.1101/gr.2122004. PMC 442147. PMID 15231747.













-

Popular posts from this blog

澳門輕軌系統

Image
本文或本章節是關於未來的公共运输建設或計划。 未有可靠来源的臆測內容可能會被移除，現時內容可能與竣工情況有所出入。 本文或本章節是關於澳門未來的建設或計畫 。 它可能包含推测的性质的信息，可能與竣工情況有所出入。 body.skin-minerva .mw-parser-output table.infobox caption{text-align:center} 澳門輕軌系統 葡萄牙語： Sistema de Metro Ligeiro de Macau 英语： Macau Light Rapid Transit System (Macau LRT System) 概覽 營運地區   澳門 服務類型 輕軌運輸 车站总数 氹仔線：11個 澳門半島線：10個 起訖站点 關閘 正線总数 3條 主要路線 海洋 - 氹仔碼頭 路線等級 輕軌 主要車站 蓮花口岸、 機場、氹仔碼頭 技術數據 路線長度 氹仔線：9.3公里 軌道標準 膠輪路軌系統 动力方式 第三軌供電 750V 車輛基地 計劃興建總數11個： 澳門半島6個，氹仔5個 运营信息 營運時期 氹仔線：預計於2019年 运营单位 港鐵（澳門）（2019年－2023年） 澳門輕軌股份有限公司（2023年後） 網站 http://www.git.gov.mo 路線圖 各期工程完成後的路線走向（模擬）圖 澳門輕軌系統（未來） 圖例 關閘 馬場北 馬場東 青洲 A區車廠 筷子基 新城A區01 紅街市
Read more

水泉澳邨

Image
水泉澳邨 //upload.wikimedia.org/wikipedia/commons/6/66/Shui_Chuen_O_Estate_Overview_2016.jpg 水泉澳邨航拍圖 房屋機構 香港房屋委員會 所屬地區 沙田區 屋邨類別 租住屋邨 入伙年份 2015年至2017年 樓宇座數 18 單位數目 11123 單位面積 151.23-397.73 呎（ft²） 住戶數目 10900 （截至2017年6月30日情況） 認可人口 28200 （截至2017年6月30日情況） 水泉澳邨內貌（2016年3月） 水泉澳邨 （ 英语： Shui Chuen O Estate ） [1] 是香港房屋委員會轄下的一個公共屋邨。全邨共分4期興建及管理，第1及2期樓宇由水泉澳邨辦事處管轄，第3及4期樓宇則由水泉澳邨辦事處分處管轄。項目編號為ST41，但已列入擴展市區配屋區內，位於香港新界沙田區水泉澳（沙田第52區）博泉街1號，已經興建18座樓高25至30層依山而建的住宅樓宇，共提供11,123個出租公屋單位，可容納人口逾29,000多人及水泉澳廣場，場內設有59個商舖及一個整體出租街市。水泉澳邨將設有行人天橋和升降機塔，接通博康邨和港鐵馬鞍山綫的沙田圍站；邨內亦設有公共交通交匯處及泊車位，方便居民出行。 整個項目於2015年4月至2017年3月分階段落成。整個項目由房屋署總建築師（1）負責總體設計；而詳細設計則拆細並以外判服務合約方式，第1及4期判給了周林建築師有限公司；第2A期（明泉樓、社會福利大樓、巴士總站、天橋及商場）及第3期（茂泉、林泉、修泉及竹泉樓）判給了興業建築師事務所有限公司及第2B期（月泉及映泉樓）判給了李景勳、雷煥庭建築師事務所；而第2C期（城泉及河泉樓）則由房屋署自行負責細部設計。全邨的總承建商是中國建築工程（香港）有限公司。 水泉澳邨共有18座出租公屋大樓，共分4期興建，第1期於2015年4月至7月底分2個階段完工，第2期在2016年3月至11月底分4個階段完工，第3期已於2017年2月完工交樓，第4期的嶺泉樓早已於2016年8月完工入伙，而餘下的崇泉、山泉及峻泉樓則由20
Read more

Indian Forest Service

Image
Indian Forest Service Service Overview Preceding service Imperial Forest Service (1864 to 1935) Year of Constitution 1966 Country India Staff College Indira Gandhi National Forest Academy (IGNFA), Dehradun, Uttarakhand Cadre Controlling Authority Ministry of Environment, Forests and Climate Change Legal personality Governmental: Government service General nature Administration of Forest and Wildlife resources Cadre strength 3131 (2182 Direct Recruits and 949 Promotion Posts) Website ifs.nic.in Service Chief Director General of Forests Siddhanth Das, IFS (1982 Batch, Odisha Cadre) [1] Head of the All India Civil Services Cabinet Secretary Pradeep Kumar Sinha, IAS Indian Forest Service (भारतीय वन सेवा) [2] is one of the three All India Services of the Government of India. The other two All India Services being the Indian Administrative Service (IAS) and the Indian Police Service (IPS). [3] [4] [5] It was constituted in
Read more